214 related articles for article (PubMed ID: 20502053)
21. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
22. Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.
Abreu AP; Noel SD; Xu S; Carroll RS; Latronico AC; Kaiser UB
Mol Endocrinol; 2012 Aug; 26(8):1417-27. PubMed ID: 22745195
[TBL] [Abstract][Full Text] [Related]
23. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
[TBL] [Abstract][Full Text] [Related]
24. Triallelic digenic mutation in the prokineticin 2 and GNRH receptor genes in two brothers with normosmic congenital hypogonadotropic hypogonadism.
Méndez JP; Zenteno JC; Coronel A; Soriano-Ursúa MA; Valencia-Villalvazo EY; Soderlund D; Coral-Vázquez RM; Canto P
Endocr Res; 2015; 40(3):166-71. PubMed ID: 25531638
[TBL] [Abstract][Full Text] [Related]
25. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
[TBL] [Abstract][Full Text] [Related]
26. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract][Full Text] [Related]
27. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Okumura T; Ikeda M; Okochi T; Kinoshita Y; Kawashima K; Yamanouchi Y; Ozaki N; Iwata N
Neuromolecular Med; 2009; 11(2):114-22. PubMed ID: 19544013
[TBL] [Abstract][Full Text] [Related]
28. Cytokine properties of prokineticins.
Monnier J; Samson M
FEBS J; 2008 Aug; 275(16):4014-21. PubMed ID: 18647349
[TBL] [Abstract][Full Text] [Related]
29. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
[TBL] [Abstract][Full Text] [Related]
30. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
[TBL] [Abstract][Full Text] [Related]
31. Human GnRH deficiency: a unique disease model to unravel the ontogeny of GnRH neurons.
Balasubramanian R; Dwyer A; Seminara SB; Pitteloud N; Kaiser UB; Crowley WF
Neuroendocrinology; 2010; 92(2):81-99. PubMed ID: 20606386
[TBL] [Abstract][Full Text] [Related]
32. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2.
Matsumoto S; Yamazaki C; Masumoto KH; Nagano M; Naito M; Soga T; Hiyama H; Matsumoto M; Takasaki J; Kamohara M; Matsuo A; Ishii H; Kobori M; Katoh M; Matsushime H; Furuichi K; Shigeyoshi Y
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4140-5. PubMed ID: 16537498
[TBL] [Abstract][Full Text] [Related]
33. The puzzles of the prokineticin 2 pathway in human reproduction.
Balasubramanian R; Plummer L; Sidis Y; Pitteloud N; Martin C; Zhou QY; Crowley WF
Mol Cell Endocrinol; 2011 Oct; 346(1-2):44-50. PubMed ID: 21664414
[TBL] [Abstract][Full Text] [Related]
34. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
Ribeiro RS; Abucham J
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
[TBL] [Abstract][Full Text] [Related]
35. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.
Pasquali D; Rossi V; Staibano S; De Rosa G; Chieffi P; Prezioso D; Mirone V; Mascolo M; Tramontano D; Bellastella A; Sinisi AA
Endocrinology; 2006 Sep; 147(9):4245-51. PubMed ID: 16763065
[TBL] [Abstract][Full Text] [Related]
36. Isolated cryptorchidism: no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism.
Laitinen EM; Tommiska J; Virtanen HE; Oehlandt H; Koivu R; Vaaralahti K; Toppari J; Raivio T
Mol Cell Endocrinol; 2011 Jul; 341(1-2):35-8. PubMed ID: 21664240
[TBL] [Abstract][Full Text] [Related]
37. TBX20 Regulates Angiogenesis Through the Prokineticin 2-Prokineticin Receptor 1 Pathway.
Meng S; Gu Q; Yang X; Lv J; Owusu I; Matrone G; Chen K; Cooke JP; Fang L
Circulation; 2018 Aug; 138(9):913-928. PubMed ID: 29545372
[TBL] [Abstract][Full Text] [Related]
38. Prokineticin-signaling pathway.
Ngan ES; Tam PK
Int J Biochem Cell Biol; 2008; 40(9):1679-84. PubMed ID: 18440852
[TBL] [Abstract][Full Text] [Related]
39. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
40. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
